Literature DB >> 15850680

Otorhinolaryngological manifestations of the mucopolysaccharidoses.

M A Simmons1, I A Bruce, S Penney, E Wraith, M P Rothera.   

Abstract

The mucopolysaccharidoses (MPS) are a family of related inherited metabolic disorders where, due to specific lysosomal enzyme deficiencies, partially degraded glycosaminoglycans (GAGs) accumulate in the body's cells. Due to the ubiquitous nature of GAGs in the body this deposition can occur in many tissue types and may interfere with cellular function. Although these conditions are rare, there is a propensity for the disease process to cause problems with the function of the ears, noses and throats of affected patients. In this review, we present an overview of the clinical manifestations of MPS in general and highlight the problems specifically presenting in the field of otorhinolaryngology.

Entities:  

Mesh:

Year:  2005        PMID: 15850680     DOI: 10.1016/j.ijporl.2005.01.017

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  38 in total

1.  Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.

Authors:  Annerose Keilmann; Todsaporn Nakarat; Iain A Bruce; David Molter; Gunilla Malm
Journal:  J Inherit Metab Dis       Date:  2011-08-25       Impact factor: 4.982

2.  Age-related functional and histopathological changes of the ear in the MPS I mouse.

Authors:  Patricia A Schachern; Sebahattin Cureoglu; Vladimir Tsuprun; Michael M Paparella; Chester B Whitley
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-11-13       Impact factor: 1.675

3.  Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.

Authors:  Till Koehne; Sarah Müller-Stöver; Anja Köhn; Katharina Stumpfe; Susanne Lezius; Carmen Schmid; Zoltan Lukacs; Bärbel Kahl-Nieke; Nicole Muschol
Journal:  Sleep Breath       Date:  2019-07-22       Impact factor: 2.816

4.  Upper airway obstructive disease in mucopolysaccharidoses: polysomnography, computed tomography and nasal endoscopy findings.

Authors:  F Santamaria; M V Andreucci; G Parenti; M Polverino; D Viggiano; S Montella; A Cesaro; R Ciccarelli; B Capaldo; G Andria
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

5.  Correlation Between Flexible Fiberoptic Laryngoscopic and Polysomnographic Findings in Patients with Mucopolysaccharidosis Type VI.

Authors:  Denise Rotta Ruttkay Pereira; Claudia Schweiger; Carolina F de Souza; Simone Fagondes; Denise Manica; Roberto Giugliani; Gabriel Kuhl; Paulo J C Marostica
Journal:  JIMD Rep       Date:  2015-11-29

6.  Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.

Authors:  Paul Harmatz; Zi-Fan Yu; Roberto Giugliani; Ida Vanessa D Schwartz; Nathalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; J Edmond Wraith; Michael Beck; Laila Arash; Maurizio Scarpa; David Ketteridge; John J Hopwood; Barbara Plecko; Robert Steiner; Chester B Whitley; Paige Kaplan; Stuart J Swiedler; Karen Hardy; Kenneth I Berger; Celeste Decker
Journal:  J Inherit Metab Dis       Date:  2010-02-06       Impact factor: 4.982

Review 7.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

8.  Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.

Authors:  Xudong Wu; Katherine A Steigelman; Erik Bonten; Huimin Hu; Wenxuan He; Tianying Ren; Jian Zuo; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2009-10-24

9.  Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.

Authors:  Gustavo A Moreira; Sandra O Kyosen; Camilla L Patti; Ana Maria Martins; Sergio Tufik
Journal:  Sleep Breath       Date:  2014-04-05       Impact factor: 2.816

10.  Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.

Authors:  Rolando Cimaz; Giovanni Valentino Coppa; Isabelle Koné-Paut; Bianca Link; Gregory M Pastores; Maria Rua Elorduy; Charles Spencer; Carter Thorne; Nico Wulffraat; Bernhard Manger
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-23       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.